Meet Floris Fauchet: From Model-Based Drug Development to Martial Arts Blog Post
You may also like AllVideo Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at CertaraBlending Science & Impact in Drug Development: Felix Boakye-Agyeman,...
Transform Drug Development with Certara’s Medical Writing Expertise Blog Post
单个药物开发成本已逾 2.6 billion 美元，而市场对救命疗法的需求空前迫切。Certara 致力于赋能如您般的行业领导者，重塑医学写作在加速药物开发进程中的关键角色。
Unleashing the Power of Patents: Competitive Analysis in Material Science [Korean webinar] Blog Post
[event_date_range]
Protect Confidential Information in Investigational Drug Submissions Blog Post
Honz Slipka 2025 年 3 月 20 日 Health regulatory agencies require pharmaceutical companies to protect study participants’ personal information (PI) within regulatory drug submissions. In addition, pharmaceutical organizations should avoid disclosing company-related...
Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study Blog Post
Publication: The Lancet HIV Objective The IMPAACT 2017/MOCHA study, a phase 1/2 multicenter trial across five countries, assessed the safety, antiviral activity, and pharmacokinetics of long-acting injectable cabotegravir and rilpivirine... Certara & A2Healthcare accelerate Model-informed Drug Development (MIDD) adoption in Japan Blog Post
This new partnership provides Japanese biopharma companies greater access to the latest biosimulation and regulatory solutions to accelerate drug development. RADNOR, PA – 2025 年 3 月 18 日 – Certara, Inc. （纳斯达克股票代...
Phoenix Hosted: Cloud-Based PK/PD Software for Smarter, Faster Research Blog Post
In this on demand webinar, you’ll discover why Phoenix Hosted is the ideal solution for R&D companies of all sizes.
